The Government of India will be procuring Biological E’s Corbevax coronavirus vaccine at Rs 290 for two doses, CNBC-TV18 reported. Private hospitals will be procuring two doses of the Corbevax COVID-19 vaccine for Rs 800.
The Centre had reportedly paid an advance of Rs 21,500 crore to Biological E in 2021 for 300 million doses of the vaccine.
On March 16, India began the inoculation drive for children aged 12 to 14 years, administering only the Corbevax COVID-19 vaccine to the beneficiaries. Two doses of Biological E’s intramuscular vaccine would be administered to the kids at an interval of 28 days.
Also read: COVID-19 | India begins vaccinating children aged 12-14 years
Hyderabad-based Biological E developed Corbevax in collaboration with the Texas Children’s Hospital Centre for Vaccine Development and Baylor College of Medicine in Houston, Texas. It is “India’s first indigenously developed protein subunit vaccine against Covid-19”. Corbevax uses a recombinant protein platform to target the spike protein on the virus particle’s surface.
In February this year, Corbevax received emergency use authorisation (EUA) from the DCGI for use on kids aged 12 years and above.
Follow our coverage of the coronavirus crisis here
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
